Folks,
The speculation (I emphasise, SPECULATION) that Xceed will float their subsidiary, that owns the polymer stent technology in which Medtronic is interested, is what I believe the market is hoping to hear announced.
But this rumour, that was circulated a fortnight ago, has, to my knowledge, no foundation in fact.
Unless, of course someone far more informed is willing to tell us more about it.
Caveat: I own XBL.
(Sir) Lunchalot
XBL
xceed biotechnology ltd
